AA

Ajay Amerlal Melwani

Active Director Director DIN 00521620
DIN 00521620 First appointment Oct 1991 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Oct 1991
Shareholding value •••• Premium profile

About Ajay Amerlal Melwani

Data last updated:

Ajay Amerlal Melwani is a Director at Vivalavita Pharmaceuticals Private Limited (since 2012), Director at Sirius Pharmaceuticals Private Limited (since 1991) and Director at Trugood Pharmagenics Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma, Paper and Wood. The 2 current companies with reported revenue have a combined latest revenue of ₹4.63 Cr; the largest is Vivalavita Pharmaceuticals Private Limited at ₹2.47 Cr (FY 2025). Earlier, Ajay Amerlal Melwani was a Director at Vivalavita Investments Advisor Private Limited (2012–2014) and Director at Sirius Holdings Private Limited (1994–2019).

DIN 00521620
Primary Designation Director
Industry Pharma
First Appointment 09 Oct 1991
Oldest Company Age 35 yrs
Largest company Vivalavita Pharmaceuticals Private Limited · ₹2.47 Cr (FY 2025)
Combined revenue ₹4.63 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Feb 20122012₹2.47 Cr (FY 2025)Active
Director09 Oct 19911991₹2.16 Cr (FY 2024)Active
Trugood Pharmagenics Private Limited U21009MH2025PTC440074
Director14 Feb 20252025Active
Aout Beauty Private Limited U20237MH2023PTC408358
Director09 Aug 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Feb 20122012Active
Sirius Holdings Private Limited U65990MH1994PTC080172
Director08 Aug 19941994₹7 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sirius Pharmaceuticals Private Limited
Vivalavita Pharmaceuticals Private Limited
Trugood Pharmagenics Private Limited
Aout Beauty Private Limited
Premium access

Shareholding and investment profile for Ajay Amerlal Melwani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajay Amerlal Melwani

Ajay Amerlal Melwani currently holds 4 directorships: Vivalavita Pharmaceuticals Private Limited (Director, since 23 Feb 2012, revenue ₹2.47 Cr (FY 2025)); Sirius Pharmaceuticals Private Limited (Director, since 09 Oct 1991, revenue ₹2.16 Cr (FY 2024)); Trugood Pharmagenics Private Limited (Director, since 14 Feb 2025); Aout Beauty Private Limited (Director, since 09 Aug 2023).

Ajay Amerlal Melwani was first appointed on 09 Oct 1991 as Director at Sirius Pharmaceuticals Private Limited. The most recent appointment on record is 14 Feb 2025 at Trugood Pharmagenics Private Limited.

The 2 current companies of Ajay Amerlal Melwani that report revenue have a combined latest revenue of ₹4.63 Cr: Vivalavita Pharmaceuticals Private Limited ₹2.47 Cr (FY 2025); Sirius Pharmaceuticals Private Limited ₹2.16 Cr (FY 2024).

Ajay Amerlal Melwani held 2 earlier board appointments: Vivalavita Investments Advisor Private Limited (Director, 21 Feb 2012 to 08 Feb 2014); Sirius Holdings Private Limited (Director, 08 Aug 1994 to 06 Nov 2019).

The current boards of Ajay Amerlal Melwani's companies include Ayush Ajay Melwani (Vivalavita Pharmaceuticals Private Limited), Sarabjit Singh Bhopinder Singh Muddar (Trugood Pharmagenics Private Limited), Saumya Ajay Melwani (Aout Beauty Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available